Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up

Introduction and objectives: Progressive familial intrahepatic cholestasis type 3 (PFIC-3) is a rare autosomal recessive cholestatic liver disorder caused by mutations in the ABCB4 gene. The aim of this study was to present the phenotypic and genotypic spectrum of 4 Polish PFIC-3 patients diagnosed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patryk Lipiński, Elżbieta Ciara, Dorota Jurkiewicz, Rafał Płoski, Marta Wawrzynowicz-Syczewska, Joanna Pawłowska, Irena Jankowska
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/9a46db97073649f0ab4e2caea1806267
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a46db97073649f0ab4e2caea1806267
record_format dspace
spelling oai:doaj.org-article:9a46db97073649f0ab4e2caea18062672021-11-18T04:46:01ZProgressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up1665-268110.1016/j.aohep.2021.100342https://doaj.org/article/9a46db97073649f0ab4e2caea18062672021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1665268121000417https://doaj.org/toc/1665-2681Introduction and objectives: Progressive familial intrahepatic cholestasis type 3 (PFIC-3) is a rare autosomal recessive cholestatic liver disorder caused by mutations in the ABCB4 gene. The aim of this study was to present the phenotypic and genotypic spectrum of 4 Polish PFIC-3 patients diagnosed in a one-referral centre. Materials and methods: The study included 4 patients with cholestasis and pathogenic variants in the ABCB4 gene identified by next-generation sequencing (NGS) of a targeted-gene panel or whole exome sequencing (WES). Clinical, laboratory, histological, and molecular data were collected. Results: Four patients (three males) were identified. The age at first noted clinical signs and symptoms was 6, 2.5, 14, and 2 years respectively; the mean age was 6 years. Those signs and symptoms include pruritus (2 out of 4 patients) and hepatomegaly with splenomegaly (4 out of 4 patients). The age at the time of referral to our centre was 9, 3, 15, and 2.5 years respectively, while the mean age was 7 years. Chronic cholestatic liver disease of unknown aetiology was established in all of them. The NGS analysis was performed in all patients at the last follow-up visit. Three novel variants including c.902T>A, p.Met301Lys, c.3279+1G>A, p.?, and c.3524T>A, p.Leu1175His were identified. The time from the first consultation to the final diagnosis was 14, 9, 3, and 1 year respectively; the mean was 6.8 years. A detailed follow-up was presented. Conclusions: The clinical phenotype of PFIC-3 could be variable. The clinical and biochemical diagnosis of PFIC-3 is difficult, thus the NGS study is very useful in making a proper diagnosis.Patryk LipińskiElżbieta CiaraDorota JurkiewiczRafał PłoskiMarta Wawrzynowicz-SyczewskaJoanna PawłowskaIrena JankowskaElsevierarticleCholestasisProgressive familial intrahepatic cholestasisNext-generation sequencingLiver transplantationChildrenSpecialties of internal medicineRC581-951ENAnnals of Hepatology, Vol 25, Iss , Pp 100342- (2021)
institution DOAJ
collection DOAJ
language EN
topic Cholestasis
Progressive familial intrahepatic cholestasis
Next-generation sequencing
Liver transplantation
Children
Specialties of internal medicine
RC581-951
spellingShingle Cholestasis
Progressive familial intrahepatic cholestasis
Next-generation sequencing
Liver transplantation
Children
Specialties of internal medicine
RC581-951
Patryk Lipiński
Elżbieta Ciara
Dorota Jurkiewicz
Rafał Płoski
Marta Wawrzynowicz-Syczewska
Joanna Pawłowska
Irena Jankowska
Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up
description Introduction and objectives: Progressive familial intrahepatic cholestasis type 3 (PFIC-3) is a rare autosomal recessive cholestatic liver disorder caused by mutations in the ABCB4 gene. The aim of this study was to present the phenotypic and genotypic spectrum of 4 Polish PFIC-3 patients diagnosed in a one-referral centre. Materials and methods: The study included 4 patients with cholestasis and pathogenic variants in the ABCB4 gene identified by next-generation sequencing (NGS) of a targeted-gene panel or whole exome sequencing (WES). Clinical, laboratory, histological, and molecular data were collected. Results: Four patients (three males) were identified. The age at first noted clinical signs and symptoms was 6, 2.5, 14, and 2 years respectively; the mean age was 6 years. Those signs and symptoms include pruritus (2 out of 4 patients) and hepatomegaly with splenomegaly (4 out of 4 patients). The age at the time of referral to our centre was 9, 3, 15, and 2.5 years respectively, while the mean age was 7 years. Chronic cholestatic liver disease of unknown aetiology was established in all of them. The NGS analysis was performed in all patients at the last follow-up visit. Three novel variants including c.902T>A, p.Met301Lys, c.3279+1G>A, p.?, and c.3524T>A, p.Leu1175His were identified. The time from the first consultation to the final diagnosis was 14, 9, 3, and 1 year respectively; the mean was 6.8 years. A detailed follow-up was presented. Conclusions: The clinical phenotype of PFIC-3 could be variable. The clinical and biochemical diagnosis of PFIC-3 is difficult, thus the NGS study is very useful in making a proper diagnosis.
format article
author Patryk Lipiński
Elżbieta Ciara
Dorota Jurkiewicz
Rafał Płoski
Marta Wawrzynowicz-Syczewska
Joanna Pawłowska
Irena Jankowska
author_facet Patryk Lipiński
Elżbieta Ciara
Dorota Jurkiewicz
Rafał Płoski
Marta Wawrzynowicz-Syczewska
Joanna Pawłowska
Irena Jankowska
author_sort Patryk Lipiński
title Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up
title_short Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up
title_full Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up
title_fullStr Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up
title_full_unstemmed Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up
title_sort progressive familial intrahepatic cholestasis type 3: report of four clinical cases, novel abcb4 variants and long-term follow-up
publisher Elsevier
publishDate 2021
url https://doaj.org/article/9a46db97073649f0ab4e2caea1806267
work_keys_str_mv AT patryklipinski progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
AT elzbietaciara progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
AT dorotajurkiewicz progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
AT rafałpłoski progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
AT martawawrzynowiczsyczewska progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
AT joannapawłowska progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
AT irenajankowska progressivefamilialintrahepaticcholestasistype3reportoffourclinicalcasesnovelabcb4variantsandlongtermfollowup
_version_ 1718425054884134912